최근 글 목록
-
- 트립스플러스의 종합판인 한...
- 름달
- 2011
-
- Abolish the Korea-US FTA, ...
- 름달
- 2011
-
- 건강권을 넘어선 재산권, 이...
- 름달
- 2011
-
- 전 세계 민중에 대한 집단학...
- 름달
- 2011
-
- [함께 해요] '세계의 약국'...
- 름달
- 2011
To: Park Hee-tae, the National Assembly Speaker and Nam Kyoung-pil, the Chairman of Foreign affairs, Trade and Unification Committee
Does the National Assembly of South Korea want to be a prime offender of the HIV/AIDS epidemic? Abolish the Korea-US FTA, a total composite of TRIPS-plus right now!
Evaluating global responses on HIV/AIDS of the past 10 years, the UNAIDS suggested 3 Zeros-Zero new infection, Zero AIDS-related death and Zero discrimination, which is a new coping strategy hereafter. Then June 2011, UN state parties agreed on “15by15” to make zero AIDS-related deaths in the UN general assembly high level meeting on HIV/AIDS. The “15by15” is a decision to commit the world to get 15 million people living with HIV/AIDS on medication (ARV) by 2015. There are 3/5 out of 15 million PLWHA who need treatment but cannot get medicines, and it is scientifically proved that the AIDS treatment itself is not only saving lives, but breaking the cycle of new infections. According to the UNAIDS, about 6.6 million people were receiving antiretroviral therapy in low- and middle-income countries at the end of 2010, that is a nearly 22-fold increase compared to 2001. Accessibility to the right treatment has increased due to the low price generic medicines. However, there are still 9 million people living with HIV/AIDS who are not able to access to anti-AIDS medicines.
Nevertheless, procedures of trade agreements which will incapacitate the “15by15”, a global commitment of the UN state parties, are ongoing now. Through India-EU FTA, TPPA (Trans-Pacific Partnership Agreement), ACTA (Anti-Counterfeiting Trade Agreement), and Korea-US FTA, European Union and the U.S. intend to protect intellectual property rights stronger than TRIPS. In Korea, so called ‘TRIPS-plus’ which includes approval-patent linkage, data exclusivity, independent review process, medicines & medical devices committee, and the investor-state dispute is expected to be concluded. Even in the U.S., “approval-patent linkage” which the U.S. government imposes the most, shifts the burden of expensive medicines to the people, causing the abuse of the patent system and the unfairly delay of generic competition. After the “approval-patent linkage” being adopted by Canada through NAFTA, Korea is going to become the third country in the world bringing in the “approval-patent linkage”. If the Korea-US FTA would be ratified, it would be distinctly not only causing a spurt in prices of medicines by delaying generic version, but also paralyzing independent policy establishment process over insurance pricing decision and national health care system. Moreover, imposing “independent review process” and “medicines & medical devices committee” means that it become difficult to amend national medicines policies without consents of the U.S. government. Furthermore, Korea-U.S. FTA contains terrifying “investor-state dispute” which is able to incapacitate public policies such as free medical supply, free education and free health care. Besides, 8 countries including South Korea, the U.S., Canada and Japan signed the Anti-Counterfeiting Trade Agreement (ACTA) in Tokyo on October 2, 2011. There is a dangerous possibility in ACTA to obstruct export and import of generic medicines.
More significant issue is that the Korea-US FTA will not be ended between the U.S. and South Korea. South Korea is willing to be in the front line of exporting European FTA and American FTA models. Since 2006, EU aggressively takes a new FTA policy aiming to absolutely eliminate tariff and non-tariff barriers, and the first main targets are South Korea and India. The Korea-EU FTA which came into effect from July, 2011, contains a border measure to let blocking export and import of generic medicines possible. The U.S. is in the position to make the Korea-US FTA as a base for FTAs throughout the Asia-Pacific region. If the Korea-US FTA would be ratified which includes approval-patent linkage, data exclusivity, independent review process, medicines & medical devices committee, and the investor-state dispute and became a “Living Agreement”, it might be the most powerful and comprehensive FTA in existence, could be forced on other countries by the Korea and the U. S. governments. In a word, even though the U.S. and Korea governments made a commitment to the “15by15” June, 2011 in New York, they push other countries to impose TRIPS-plus by using FTA in the very front.
If the Korea-US FTA would be ratified, the goal which is committed to provide antiretroviral medicines additionally to 9 million people, could not be achieved but also brought a result making people living with HIV/AIDS hard to maintain even a current status.
Does the Korean National Assembly want to be a prime offender of the AIDS epidemic by driving PLWHV of the whole world into deaths?
Stop the Korea-US FTA Right Now, Stick to the “15by15” as an UN state party!
October, 14th, 2011
<South Korea>
Korean People living with HIV/AIDS Group 'LOVE4ONE'
Solidarity for HIV/AIDS Human Rights Nanuri+ [Public Pharmaceutical Center / Solidarity for Lesbian Gay Bisexual Transgender Human Rights of Korea / Korean Gay Men’s Human Rights Group/ Korean Pharmacists for Democratic Society]
Korean Progressive Network Jinbonet
Intellectual Property Left
Network for Global Activism
Cultural Action
Korean House for International Solidarity
Human Rights Solidarity for New Society
SARANGBANG group for Human Rights
Democratic Workers' Solidarity
GG:Network for Sex Workers Rights
Solidarity Against Disability Discrimination
Information & Culture Nuri for the Disabled Korean
Network of Accessible Environments for All
Disability and Humanrights In Action
Korean Medical Action Groups for Health Rights
Health Right Network
Dary
Democratic Labor Party Sexual Minor Committee
<Foreign>
The International Treatment Preparedness Coalition(ITPC)
The Asia Pacific Network of People Living with HIV/AIDS(APN+)
The Asian Network of People who Use Drugs(ANPUD)
Positive Malaysian Treatment Access & Advocacy Group(MTAAG+)
Health GAP (Global Access Project)-US
The Thai Network of People living with HIV/AIDS(TNP+)
Alternative Agricultural Network-Thailand
Rural Pharmacists Foundation-Thailand
Rural Doctors Foundation-Thailand
Rural Doctor Society-Thailand
Drug Study Group-Thailand
Thai NGO Coalition on AIDS-Thailand
Foundation for AIDS Rights-Thailand
AIDS ACCESS Foundation-Thailand
Foundation for Consumers-Thailand
Health and Development Foundation-Thailand
Thai Holistic Health Foundation-Thailand
FTA Watch-Thailand
Ecological Alert and Recovery(EARTH)–Thailand
Health Consumers Protection Program-Thailand
Drug System Monitoring and Development Program-Thailand
Social Pharmacy Research Unit, Chulalongkorn University-Thailand
Uttar Pradesh Network of People Living With HIV/AIDS (UPNP+) - Naresh Yadaw
Madhya Pradesh Network of People Living With HIV/AIDS (MPNP+) - rajpal Yadaw
Network of maharashtra by people living with HIV (NMP+) - Prashant Yende
Rajsthan network of people living with HIV (RNP+) - Brijesh Dube
Ahamadnagar Network of People Living With HIV/AIDS - Amale
Kolhapur Network of People Living With HIV/AIDS - Yuvraj shinde
Gadchiroli Network of People Living With HIV/AIDS - Vijay Bhende
Akola Network of People Living With HIV/AIDS - Shunbhangi Kharat
Mumbai Network of People Living With HIV/AIDS - Bharati Sonawane
Thane Network of People Living With HIV/AIDS - Shabana Patel
Beed Network of People Living With HIV/AIDS - Mangal Moholkar
latur Network of People Living With HIV/AIDS - Shila
Contact:
Name: Jaecheon Kim
Organization: Solidarity for HIV/AIDS Human Rights Nanuri+
Email address: jaekim1980@gmail.com
Name: Miran Kwon
Organization: Solidarity for HIV/AIDS Human Rights Nanuri+
Email address: rmdal76@hanmail.net
최근 댓글 목록